loader

World Tenders & Procurement Opportunities

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

World Biggest Tenders Source

This tender with title Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens. -- Pharmaceutical products has been published on Bidding Source portal dated 19 May 2022 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Pharmaceutical products

General Information

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Pharmaceutical products
Invitation for Bids
2022/S 096-264480
Germany
Germany-Hanover
19 May 2022
30 Sep 2024
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 240226-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1a) - 238051-2024 Germany Pharmaceutical products – GWQ - Methocarbamol (i.v. und FTA 12 St) - 239930-2024 Germany Pharmaceutical products – Drug tender_2024 a - 240617-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1b) - 235137-2024 Germany Pharmaceutical products – Open house drug discount agreements Interferon beta-1a, finished drug name Avonex, ATC L03AB07 - 224063-2024 Germany Pharmaceutical products – Open house drug discount agreements Vilanterol and umeclidinium bromide, ATC R03AL03 - 224747-2024 Germany Pharmaceutical products – conclusion of a non-exclusive Discount agreement according to Section 130a paragraph 8 or 130c paragraph 1 SGB V for the period from June 1st, 2024 to usually May 31st, 2026 - 227152-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient melatonin (N05CH01), excluding prolonged-release tablets with an effective strength of 2mg as part of a so-called open-house model. - 224643-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredients timolol and brinzolamide (S01ED67) as part of a so-called open house model. - 223838-2024 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans